Back to search

A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Pomalidomide for Multiple Myeloma

Multiple Myeloma
Clinicaltrials.gov:
EU CTIS:
#2024-515316-44-00
Other:
#79635322MMY1002
Interested in this trial?
Subscribe or share this trial
Countries:
  • Australia,
  • Israel,
  • Netherlands,
  • Spain
Loading...
Enrolling
Waratah, Australia, 2298
Enrolling
Haifa, Israel, 3436212
Enrolling
Jerusalem, Israel, 9112001
Enrolling
Salamanca, Spain, 37007
Enrolling
Barcelona, Spain, 08036
Enrolling
Clayton, Australia, 3168
Enrolling
Melbourne, Australia, 3000
Enrolling
Ramat Gan, Israel, 52621
Enrolling
Fitzroy, Australia, 3065
Enrolling
Tel Aviv, Israel, 64239
Enrolling
Utrecht, Netherlands, 3584 CX
Enrolling
Groningen, Netherlands, 9713 GZ
Enrolling
Amsterdam, Netherlands, 1081 HV
Enrolling
Wollongong, Australia, 2500
#
More than 50 sites in this region
#
More than 10 sites in this region
#
Less than 10 sites in this region
Map pin icon representing individual study sites
Individual sites
Access detailed information on the trial:
© Johnson & Johnson and its affiliates 2026
J&J Clinical Trials